[PPARgamma and metabolic syndrome]
1Department of Endocrinology and Metabolism, Graduate School of Medicine, Yokohama City University, Yokohama 236-0004.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|June 28, 2007
Summary
Peroxisome proliferator-activated receptors (PPARs), particularly PPARgamma, play a key role in metabolic diseases. Modulating PPARgamma activity offers therapeutic potential for type 2 diabetes and obesity.
Area of Science:
- Metabolic diseases research
- Nuclear receptor signaling
- Diabetes pathogenesis
Background:
- Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors involved in metabolic regulation.
- PPAR subtypes (alpha, beta, and gamma) have distinct roles and expression patterns.
- Dysregulation of PPARgamma is implicated in metabolic diseases like insulin resistance and type 2 diabetes.
Purpose of the Study:
- To investigate the role of PPARgamma in the pathogenesis of type 2 diabetes.
- To explore the effects of modulating PPARgamma activity on metabolic parameters.
- To understand the therapeutic potential of targeting PPARgamma.
Main Methods:
- Utilized heterozygous PPARgamma-deficient mice fed a high-fat diet.
- Analyzed the impact of a Pro12Ala polymorphism in the human PPARgamma2 gene.
- Investigated the effects of an RXR antagonist and thiazolidinedione (TZD) on PPARgamma activity and metabolic outcomes.
Main Results:
- PPARgamma deficiency protected mice from diet-induced insulin resistance and adipocyte hypertrophy.
- A human PPARgamma2 polymorphism was linked to reduced type 2 diabetes risk.
- Moderate PPARgamma reduction improved insulin sensitivity and reduced obesity by enhancing fatty-acid metabolism.
- Thiazolidinedione (TZD) treatment promoted adipocyte differentiation, alleviated insulin resistance, and showed anti-atherogenic effects, despite increasing obesity.
Conclusions:
- PPARgamma activity critically influences the development of insulin resistance and obesity.
- Targeting PPARgamma offers a promising strategy for managing type 2 diabetes and metabolic syndrome.
- Understanding PPARgamma's regulatory mechanisms is vital for developing effective drugs for metabolic disorders.
Related Concept Videos
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:19Regulation of Metabolism
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
01:19Overview of Carbohydrate Metabolism
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:28Global Regulatory Systems
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...